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Abstract 
Through screening of proteases derived from Bordetella pertussis, we identified an 
alanine aminopeptidase (AAP) activity capable of specifically degrading alanyl 
β-naphthylamide (Ala-βNA). We subsequently conducted enzymatic studies to 
determine the differences between the AAP from B. pertussis and a rat brain-derived 
protease that has the same substrate specificity. After a series of purification processes, 
the pertussis AAP activity was purified 90-fold, and the rat brain AAP was purified 
18-fold. The optimum pH for the pertussis AAP was approximately 8.0, and activity 
was maintained up to pH 10. For the rat brain AAP, the optimum pH was 
approximately 6.5 to 7.0, and 50% of the activity was retained even at pH 5.0 or pH 9.0. 
Although strong inhibition by p-chloromercuribenzoic acid (PCMB) was observed, 
both enzymes are most likely to be metallo-enzymes, as evidenced by inhibition by 
bestatin and o-phenanthroline. This report is, to our knowledge, the first description of 
the enzymatic properties of AAP in B. pertussis, including classification of the activity 
as a cytosolic alanine aminopeptidase (EC 3.4.11.14). The enzyme is stable between pH 
7 and 10, with pH 8 being the optimum. It retained some activity at lower temperatures, 
exhibiting 20% activity at 10°C, but had less activity at temperatures exceeding 40°C. 
We have now completed cloning of the B. pertussis AAP-encoding gene and are 
investigating expression of recombinant AAP protein in Escherichia coli and its 
enzymatic activity.  
 
Introduction 
Bordetella pertussis is an aerobic, highly infectious, Gram-negative coccobacillus that 
causes whooping cough (pertussis), an acute respiratory tract infection in humans 
 - 52 - 
characterized by paroxysmal coughs and inspiratory stridor (1,2,3).  
B. pertussis utilizes amino acids, not sugars, as its energy and nitrogen sources. Based 
on its characteristics, we postulated that there may be specific proteases that are 
necessary for the release of amino acids from substrate components in media. We 
therefore conducted screening for proteases derived from B. pertussis and detected an 
alanine aminopeptidase (AAP) activity that corresponds to an enzyme that specifically 
breaks down alanyl β-naphthylamide (Ala-βNA).  
We therefore purified AAP from B. pertussis to determine the protein’s enzymatic 
properties. For comparison, we also purified a rat brain AAP that is known to have the 
same substrate specificity (4) and examined the differences between these two enzymes. 
 
Materials and Methods 
1. Materials 
Rat brain was collected from SPF male Wistar rats averaging 12 weeks of age 
obtained from Japan SLC (Hamamatsu, Japan). Fast garnet GBC salt, diisopropyl- 
phosphorofluoridate (DFP), Bestatin, and Ala-βNA were purchased from Sigma (St. 
Louis, MO, USA). Phenylmethylsulfonyl fluoride (PMSF), p-chloromercuribenzoic acid 
(PCMB), and o-phenanthroline were purchased from Wako (Osaka, Japan). 
 
2. Assay for alanine aminopeptidase activity 
The enzyme activity was assayed by the method of Yoshimoto et al., with slight 
modifications for the use of Ala-βNA as the substrate (5,6). Briefly, 100 µL of enzyme 
suspension was combined with 850 µL of 20 mM Tris-HCl buffer, pH 7.6, and the 
mixture was preincubated at 37°C for 3 min. The reaction was initiated by adding 50 µL 
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of 3 mM Ala-βNA. After a 30-min incubation at 37°C, the reaction was stopped and 
color was developed by adding 0.5 mL of Fast garnet GBC (1mg/mL in 1 M acetate 
buffer, pH 4.0, containing 10% Triton X-100). The absorbance was measured at 550 nm 
at room temperature. One unit of the enzyme activity was defined as the amount of the 
enzyme that released 1 µmol of ß-naphthylamine per min at 37°C. The concentration of 
the enzyme protein was estimated spectrophotometrically by assuming an extinction 
coefficient of 10 (for a 1% solution, 1-cm path length, at 280 nm), with enzyme activity 
expressed in units per mg protein. 
 
3.  Cultivation of B. pertussis and growth conditions 
 The B. pertussis strain Tohama (7) was grown for 72 h at 37°C on Bordet-Gengou 
(BG) agar (Difco, Detroit, MI) supplemented with 1% glycerol, 20% defibrinated sheep 
blood. Liquid cultures of B. pertussis were grown as described previously in 
Stainer-Scholte medium (8). Exponentially growing B. pertussis was inoculated into 2.5 
mL of Stainer-Scholte medium to an optical density of 0.15 at 600 nm and grown for 24 
h at 37°C. Following cultivation, cells were collected by centrifugation and washed with 
Dulbecco’s modified phosphate-buffered saline (DPBS, pH7.4) and disrupted by 
sonication (Bioruputor UCD-300, 4 mins, on ice). The disrupted cell suspension was 
used for further purification of the bacterial enzyme. 
 
4.  Purification of enzyme  
All purification procedures were carried out at 4°C. The disrupted B. pertussis cell 
suspension was diluted 10-fold with 20 mM Tris-HCl buffer, pH 7.6, and fractionated 
by ammonium sulfate precipitation at 30 to 80% saturation. The purification method 
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was as previously described (5,9). Briefly, after Toyopearl HW65F gel filtration and 
DEAE-Toyopearl affinity chromatography, the active fraction was concentrated using 
ammonium sulfate precipitation. The precipitate was dissolved in 20 mM sodium 
phosphate buffer, pH 7.6, and subjected to chromatography on a hydroxyapatite column 
(3 × 10 cm). The active fractions were pooled, and then concentrated using a Vivapore 
concentrator (Vivascience).  
For purification of the rat brain enzyme, rat brain (15 g) was homogenized in 150 
mL of 20 mM Tris-HCl buffer, pH 7.6, using a glass Teflon homogenizer. As with 
purification of B. pertussis, after Toyopearl HW65F gel filtration, the active fraction 
was concentrated using ammonium sulfate precipitation. The precipitate was dissolved 
in 20 mM phosphate buffer, pH 7.6, and subjected to chromatography on a 
hydroxyapatite column (3 × 10 cm). The active fractions were pooled, and then 
concentrated using a Vivapore concentrator (Vivascience). 
 
5. pH and temperature stability 
pH stability was assessed using 20 mM sodium acetate buffer for the interval 
spanning pH 4.0 to 6.0; 10 mM sodium phosphate buffer for the interval spanning pH 
6.0 to 8.0; and 20 mM Tris-HCl buffer for the interval spanning pH 8.0 to 10.0. Activity 
at each of the various pHs was tested using the same method as described above for 
determination of enzyme activity. Temperature stability was performed at temperatures 
of 10°C, 20°C, 30°C, 37°C, 40°C, 50°C, and 60°C. Activity at each of the various 
temperatures was tested using the same method as described above for determination of 
enzyme activity. Relative activities were calculated by comparison to that of the 
respective enzyme at pH 7.6 (optimal pH of B. pertussis) and 37°C, as shown in the 
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assay for alanine aminopeptidase activity of B. pertussis. 
Curve fitting was performed by approximating curve, using Microsoft Excel. 
 
Results 
1. Purification of alanine aminopeptidase activities from B. pertussis and rat brain 
The purifications of the enzymes are summarized in Table 1. The enzymes from B. 
pertussis and rat brain were partially purified by 90-fold and 18-fold, respectively, with 
an activity recovery of approximately 20% and 8%, respectively. As shown in the 
chromatograms provided in Fig. 1, under the same chromatographic condition, the 
enzyme from B. pertussis did not adsorb onto the hydroxyapatite to flow through the 
column, while that from rat brain was eluted at a phosphate concentration of about 50 
mM. 
 
Table 1. Partial purification of alanine aminopeptidase from Bordetella pertussis and rat 
brain. 
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Fig. 1. Chromatography of alanine aminopeptidase on hydroxyapatite. 
Step 3 fraction was applied to the column (1.8 ×15 cm) equilibrated with 10 mM 
phosphate buffer, pH 7.0. Elution was performed with a linear gradient of phosphate 
buffer (10 to 200 mM).  
 
2. pH and thermal stability 
As shown in Fig. 2, the enzyme from B. pertussis was stable between pH 7 and 10, with 
pH 8 being the optimum. However, the enzyme from rat brain showed a narrower 
stability range between pH 6 and 8, with pH 6.5 to 7.0 being the optimum; the activity 
at pH 8 was less than 80% of the maximum. The mammalian enzyme was more stable 
under acidic conditions than under basic conditions. Little activity was detected for the 
bacterial enzyme at acidic pH 5. 
Temperature stability is shown in Fig. 3. The enzyme from B. pertussis retained some 
activity at lower temperatures, exhibiting 20% activity at 10°C, but had less activity at 
temperatures exceeding 40°C. In contrast, the rat brain enzyme retained some activity at 
higher temperatures of 40 to 50°C, but was inactive at temperatures of less than 20°C. 
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Fig. 2. pH stability of alanine aminopeptidase from Bordetella pertussis and rat brain. 
pH stability was estimated by using 20 mM acetate buffer at 4.0–6.0, 10 mM phosphate 
buffer at 6.0–8.0 and 20 mM Tris-HCl buffer at 8.0–10.0. These buffers were used with 
the same method of enzyme activity. 
 
 
 
 
Fig.3 Temperature stability of alanine aminopeptidase from Bordetella pertussis and rat 
brain.  
Temperature stability was estimated at 10°C, 20°C, 30°C, 37°C, 40°C, 50°C and 60°C 
respectively. These temperatures were used with the same method of enzyme activity.  
Relative activity against pH 7.6 and 37°C was calculated for each reaction. 
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3.  Effects of various peptidase inhibitors  
The effects of various inhibitors on the purified enzymes from B. pertussis and rat brain 
are shown in Table 2. Both enzymes were almost completely inhibited by bestatin and 
o-phenanthroline, indicating that those are metallo-enzymes. Although only a partial 
inhibition by EDTA was observed, this is usual for many metallo-peptidases including 
alanyl aminopeptidase (aminopeptidase N). PMSF partially inhibited the enzymes but 
DFP had no effect at all. PCMB showed relatively strong inhibition. Its bulky structure 
often affects the enzyme activity that is not dependent on thiol residue. In addition, 
divalent metal ions, ZnCl2 and MnCl2, strongly inhibited the activity.  
 
Table 2. Effects of metal and various inhibitors on the purified alanine aminopeptidase 
from Bordetella pertussis and rat brain. The enzyme was incubated with each additive 
at 37°C and for 10 min, and the residual activities of the reaction mixture were assayed 
under the standard conditions.  
 
 
 - 59 - 
Discussion 
In the present study, we purified an AAP from B. pertussis and examined its 
enzymatic properties, including comparison to an AAP from rat brain.  
B. pertussis proliferates by selectively utilizing amino acids as energy and nitrogen 
sources. We therefore postulated that this organism produces one or more specific 
proteases to digest proteins and peptides to amino acids. By conducting a screen for 
proteases derived from B. pertussis, we detected an activity that specifically breaks 
down Ala-βNA (data not shown). 
In a comparison of pH stability, the pertussis AAP exhibited an optimal pH of 
approximately 8.0, and activity was retained at pHs up to 10, indicating that this enzyme 
prefers weakly basic environments to acidic environments. Optimal pH in growth of B. 
pertussis is 7.6, and the bacterium alkalifies the culture medium from pH 7.6 to about 
9.0 as it grows (11,12). The pH stability result of the enzyme is consistent with the 
preferred pH of B. pertussis. 
The rat brain AAP showed an optimal pH of approximately 6.5 to 7.0. The 
mammalian enzyme retained 50% activity at pH 5.0; but activity was 50% or less at 
approximately pH 9.0. 
In an examination of thermal stability, the pertussis AAP retained approximately 20% 
activity at temperatures as low as 10°C, but rapidly lost activity at temperatures 
exceeding 40°C. This result is consistent with the optimal temperature of B. pertussis, 
which is 35–36.5°C, and multiplication stops at more than 37°C (11,12). In fact, growth 
of B. pertussis is inhibited at higher than 37°C. 
By contrast, rat brain AAP had an optimal temperature of approximately 50°C, 
exhibiting a rapid loss of activity at temperatures of 30°C or less. We can consent to the 
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cases that a rat has a high temperature more than 38°C also being expected and being a 
result higher temperature than B. pertussis optimum. The rectum temperature of the rat 
is considered to be about 38°C, and it may be higher in the brain. Therefore, a rat brain 
seems to have an optimum temperature range higher than B. pertussis. 
Unfortunately, both enzymes were still in partially purified form, so the molecular 
mass of these enzymes was not exclusively shown. However, characterization of 
aminopeptidase N (EC3.4.11.2) from E. coli has already been reported (10). The E. coli 
enzyme has an Mr of 99,000 and belongs to clan MA, family M1; the E. coli enzyme 
incorporates zinc in its active center (4). In humans, aminopeptidase N is also known to 
possess significant physiological functions as a receptor, irrespective of its enzymatic 
function. For example, human aminopeptidase N, which has been identified as a CD13 
antigen, is known as a receptor for coronavirus transmissible gastroenteritis virus and 
human coronavirus 229E (13,14). 
Based on differences in pH and thermal stability, it was demonstrated that the 
enzymatic properties differ between these two AAPs, even though the two enzymes are 
both proteases that degrade the same substrate. Examination of inhibition profiles 
revealed that both enzymes were completely inhibited by both bestatin and 
o-phenanthroline, suggesting that both activities depend on the presence of metals at the 
active sites. Moreover, ZnCl2 and MnCl2 also inhibited both enzymes. E. coli pepN is 
also inhibited by these metal ions and an inhibition of metallo-peptidase by divalent 
metal ions is often observed. As shown in Fig.1, the chromatogram of each AAP on 
hydroxyapatite differs between enzymes. While an enzyme of B. pertussis is eluted 
through 10mM phosphate buffer, AAP of rat brain is eluted through a high 
concentration of phosphate buffer (about 100 mM). These results indicate that 
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conformation, amino acid sequences or electrification of APP of B. pertussis is different 
from rat brain. 
Although the pertussis enzyme exhibits the same substrate specificity as E. coli PepN, 
further investigations, including structural determinations, are planned in the future. 
At the present time, we have completed cloning of the B. pertussis gene that encodes 
this AAP activity and are confirming protein expression and enzyme activity. We are 
seeking to further elucidate the role of this enzyme in B. pertussis, and hypothesize that 
this protein may be of use as an antigen of a future pertussis vaccine. 
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